Maintaining a similar anti-apoptotic effect on MCL1 as it did to BCLx, knockdown of SRSF1 significantly increases the levels of MCL1S isoform in both MCF7 and MDA-MB-231 breast cancer cell lines, and the JAr choriocarcinoma cell line [49]. Here, BCL2L1 is linked to breast carcinoma.